RAC - Charts & Price Action, page-3376

I've never been one to make share price predictions, not smart or brave enough to put it out there on the line but I think you are on the money IMO. Imagine another biotech with a drug like Bisantrene but at the absolute beginning of their journey. How much would it cost to replicate the plethora of historic data owned by RAC? I reckon 100s of millions. And plenty of years. RAC has a massive head start on the road to takeover or partnership. Combine that with savvy leadership and its looking like a perfect storm. I think the market is just starting to realise this. I must admit when I first stumbled onto RAC I looked at the historic data and thought someone had given me the answers to an upcoming exam. Not a bad feeling! Onward.